Understanding Perceptions of Hepatitis C and Its Management Among People with Experience of Incarceration in Quebec, Canada: A Qualitative Study Guided by the Common Sense Self-Regulation Model
- PMID: 39772217
- PMCID: PMC11680397
- DOI: 10.3390/v16121910
Understanding Perceptions of Hepatitis C and Its Management Among People with Experience of Incarceration in Quebec, Canada: A Qualitative Study Guided by the Common Sense Self-Regulation Model
Abstract
Hepatitis C virus (HCV) disproportionately affects certain sub-populations, including people with experience of incarceration (PWEI). Little is known about how perceptions of HCV and treatment have changed despite simplifications in testing and treatment in carceral settings. Nineteen semi-structured interviews were conducted with people living with or having a history of HCV infection released from Quebec provincial prison. Interviews were guided by the Common Sense Self-Regulation Model (CS-SRM) and aimed to explore cognitive and emotional representations of HCV and coping strategies. Among the 19 participants, seven (37%) were diagnosed with HCV in prison and 14 (74%) had previously received HCV treatment. Participants' HCV illness perceptions were influenced by fear (of HCV transmission, death, and the well-being of family) and stigma (related to HCV, injection drug use, and incarceration). While some sought education and social and professional support, others self-isolated or engaged in high-risk behaviors to cope. Despite advances in HCV treatment, PWEI continue to experience various forms of stigma and fear surrounding their HCV diagnosis, resulting in delayed HCV care. These findings provide insights into how prison-based healthcare providers can better utilize HCV illness perceptions to evaluate willingness to engage in HCV care among PWEI.
Keywords: CS-SRM; hepatitis C virus; implementation science; people with experience of incarceration; qualitative research.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: A.M., S.M., D.O.-P., A.P., G.F., C.D., J.M.G., and J.P. report no competing interests. J.C. has received research funding from ViiV Healthcare, Merck, and Gielead; consulting fees from ViiV Healthcare, Merck, and Gilead; and payment for lectures from Gilead, all outside this work. N.K. has received research funding from ViiV Healthcare, Abbvie, and Gilead; advisory fees from Gilead Sciences, ViiV Healthcare, Merck, and Abbvie; and speaker fees from Gilead Sciences, Abbvie, and Merck, all outside this work.
Figures
Similar articles
-
Factors influencing the acceptability of hepatitis C screening among people with experience of incarceration in Quebec, Canada: A qualitative descriptive study guided by the Theoretical Domains Framework.Int J Drug Policy. 2025 Sep;143:104890. doi: 10.1016/j.drugpo.2025.104890. Epub 2025 Jun 26. Int J Drug Policy. 2025. PMID: 40578044
-
Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada.Int J Drug Policy. 2024 Nov;133:104624. doi: 10.1016/j.drugpo.2024.104624. Epub 2024 Oct 18. Int J Drug Policy. 2024. PMID: 39426103
-
Identifying barriers and enablers to opt-out hepatitis C virus screening in provincial prisons in Quebec, Canada: A multilevel, multi-theory informed qualitative study with correctional and healthcare professional stakeholders.Int J Drug Policy. 2022 Nov;109:103837. doi: 10.1016/j.drugpo.2022.103837. Epub 2022 Aug 26. Int J Drug Policy. 2022. PMID: 36030569
-
Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research.Int J Drug Policy. 2021 Oct;96:103320. doi: 10.1016/j.drugpo.2021.103320. Epub 2021 Jul 11. Int J Drug Policy. 2021. PMID: 34261587 Review.
-
Using the barriers and facilitators to linkage to HIV care to inform hepatitis C virus (HCV) linkage to care strategies for people released from prison: Findings from a systematic review.J Viral Hepat. 2020 Feb;27(2):205-220. doi: 10.1111/jvh.13220. Epub 2019 Dec 11. J Viral Hepat. 2020. PMID: 31638294
Cited by
-
Perceptions about hepatitis C and barriers and enablers to screening and treatment among Egyptian immigrants to Canada: a theory-informed qualitative study.Int J Equity Health. 2025 Jul 11;24(1):203. doi: 10.1186/s12939-025-02582-4. Int J Equity Health. 2025. PMID: 40646616 Free PMC article.
-
Hepatitis C Virus: Epidemiological Challenges and Global Strategies for Elimination.Viruses. 2025 Jul 31;17(8):1069. doi: 10.3390/v17081069. Viruses. 2025. PMID: 40872783 Free PMC article. Review.
References
-
- World Health Organization Combating Hepatitis B and C to Reach Elimination by 2030. Advocacy Brief, 2016. [(accessed on 9 July 2024)]. Available online: https://iris.who.int/bitstream/handle/10665/206453/WHO_HIV_2016.04_eng.p....
-
- World Health Organization Global Health Sector Strategy on Viral Hepatitis 2016–2021: Towards Ending Viral Hepatitis. World Health Organization, 2016. [(accessed on 9 July 2024)]. Available online: https://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-....
-
- Canadian Network on Hepatitis C Blueprint to Inform Hepatitis C Elimination Efforts in Canada, 2019. [(accessed on 9 July 2024)]. Available online: https://www.canhepc.ca/sites/default/files/media/documents/blueprint_hcv....
-
- Public Health Agency of Canada People living with Hepatitis C (HCV) in Canada—Canada.ca. Government of Canada, 2022. [(accessed on 9 July 2024)]. Available online: https://canada.ca/en/public-health/services/publications/diseases-condit....
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical